Israa’iil: Shirkadda Galmed oo ku guulaysatay patent cusub oo ka hortagga cudurka beerka Koonfurta Kuuriya
Shirkadda Galmed Pharmaceuticals oo heshay patent-ka Koonfurta Kuuriya ee daaweyn cusub oo loo sameeyay cudurka beerka, taasoo kordhisay ilaalinta caalamiga ah.
Yeruusaalem, 4 December, 2025 (TPS-IL) — Shirkadda Israa’iil ee Galmed Pharmaceuticals ayaa ku dhawaaqday Khamiistii in Koonfurta Kuuriya ay siisay patent cusub oo loo isticmaalo isku-darka daawadeeda ugu muhiimsan, Aramchol, iyo Rezdiffra, oo ay samaysay shirkadda Maraykanka ee Madrigal Pharmaceuticals, si loogu daweeyo beerka fibrosis iyo MASH, oo ah cudur beerka sii xumaanaya.
Shirkadda oo fadhigeedu yahay Raamat Gaan ayaa sheegtay in patent-ka uu kordhinayo ilaalinta caalamiga ah ee Aramchol ilaa Luulyo 2042, isagoo ku daraya patent-yada jira ee Maraykanka, Yurub iyo Kanada.
